RECENT POSTS
FAST MONEY FEATURES
FAST MONEY POLLGet in the post game. Respond to our "Question of the Day" right now.
FULL SHOWSMissed an episode of Fast Money? Watch the lastest show here.
TRADE SCHOOLGrab a pencil because school is in session and the Fast Money traders are teaching class.
FAST MONEY PODCASTSDownload Fast Money onto your MP3 Player.
FAST MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
SHOP FOR FAST MONEY MERCHANDISEGet your game on with Fast Money gear.
FAST MONEY PHOTOS!Check out our scrapbook. These "pix" are guaranteed winners.
NEWSLETTERSign up and receive a recap email every Friday after the show!
FAST MONEY MOBILE ALERTSGet advanced information about the next Fast Money.
Text Size 
 |
Here’s our Fast Money Final Trade. Our gang gives you tomorrow’s best trades, right now.
Tim Seymour suggests long ArcelorMittal [MT
Loading...
()
] because they company is in talks to change a debt covenant.
Guy Adami recommends long Intel [INTC
Loading...
()
] considering it bounced off the technically important $15.78 level.
Karen Finerman likes Wells Fargo preferred
Joe Terranova thinks American Express [AXP
Loading...
()
] is a buy as a top performer in the Dow.
Click here to see other Final Trade posts.
But that’s not all. Following are more ways to trade tomorrow's market moving events.
STOCK OF THE DAY: SUNOCO
Joe Terranova recommends putting Sunoco [SUN
Loading...
()
] on your radar. It’s down 50% for the year, he counsels, and a great way to play a potential turnaround in the auto space as well as the overall economy. And could even pop if we have a hurricane, he adds.
TRADING AFTER DARK: BIOTECH BUYS
As you may know market sentiment towards Amgen [AMGN
Loading...
()
] perked up markedly on Wednesday after the beaten-down biotechnology company reported better-than-expected results from a trial of its experimental bone-protecting drug in patients with advanced breast cancer.
However, with Amgen up 14% on Wednesday how should you game this stock?
Pete Najarian says at even $60 a share Amgen still looks attractive. The new drug could be a multi-billion drug. And they have a strong pipeline.
- Halftime Report: Dubai - First Ripple Of Larger Crisis?
- Your First Move For Friday November 27th
- Web Extra: Private Equity, Conviction Buy?
- Pops & Drops: Abercrombie & Fitch, Nucor...
- Giving Thanks: Seymour
- Your Questions About... Alcoa & The Dollar
- Best Wishes Regis
- Gartman's Annual Rules For Trading
- Chartology: December Outlook
- Holiday Toy Trades
______________________________________________________
Got something to say? Send us an e-mail at and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to .
Trader disclosure: On July 8th, 2009, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Seymour Owns (AA), (AAPL), (BAC), (BX), (EEM), (FXI), (F), (INFY), (SBUX); Seymour's Firm Owns (FCX); Terranova Owns (MSFT), (XBI), (ABT), (OIH), (RIMM), (SUN) ; Adami Owns (AGU), (C), (GS), (INTC), (MSFT), (NUE), (BTU); Finerman Owns (RIG), (TBT); Finerman's Firm Owns (FCN), (MSFT), (NOK), (PBR), (RIG), (TBT), (WMT), (FLS); Finerman's Firm Owns (BAC) Preferred; Finerman Owns (BAC) Preferred; Finerman's Firm Is Short (BAC), (IYR), (IJR), (MDY), (SPY), (USO)
Data is a real-time snapshot *Data is delayed at least 15 minutes